Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OXN PR vs OxyPR in OA Pain
NCT00902837Phase 3Completed
- Sponsor
- Mundipharma
- Start
- May 2009
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of oxycodone + naloxone in osteoarthritis (OA), sponsored by Mundipharma. Started May 2009; status: completed.
02
Drugs
oxycodone + naloxone
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00902837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00902837.